Literature DB >> 33799959

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis.

Knut Brockow1, Katarzyna Plata-Nazar2, Magdalena Lange3, Bogusław Nedoszytko3, Marek Niedoszytko4, Peter Valent5,6.   

Abstract

Mastocytosis is characterized by the pathological accumulation of mast cells (MC) in various organs. In these patients, MC may degranulate and thereby contribute to clinical symptoms, especially when a concomitant allergy is present. However, MC activation can not only be induced by high-affinity receptors for IgE, but also by anaphylatoxins, neuropeptides, IgG immune complexes, complement-components, drugs, products of bacteria or parasites, as well as physical factors such as heat, cold, vibration, stress, sun, or physical effort. Symptoms due to mediators released by activated MC may develop in adults suffering from systemic mastocytosis, but also evolve in children who usually have cutaneous mastocytosis (CM). Clinically, CM is otherwise characterized by typical brown, maculopapular skin lesions or mastocytoma associated with a positive Darier's sign. Pruritus and flushing are common and blistering may also be recorded, especially in diffuse CM (DCM). Pediatric patients with mastocytosis may also have gastrointestinal, respiratory, and neurologic complaints. Although anaphylaxis is not a typical finding, pediatric patients with massive skin involvement and high tryptase levels have a relatively high risk to develop anaphylaxis. This paper reviews MC mediator-related symptoms and anaphylaxis in children with mastocytosis, with special emphasis on risk factors, triggers, and management.

Entities:  

Keywords:  anaphylaxis; children; mast cells; mastocytosis; mediator-related symptoms

Mesh:

Substances:

Year:  2021        PMID: 33799959      PMCID: PMC7962052          DOI: 10.3390/ijms22052684

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  103 in total

Review 1.  Natural history and treatment of cutaneous and systemic mastocytosis.

Authors:  Michelle Le; Barbara Miedzybrodzki; Tim Olynych; Hugo Chapdelaine; Moshe Ben-Shoshan
Journal:  Postgrad Med       Date:  2017-08-21       Impact factor: 3.840

2.  Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.

Authors:  Patrizia Bonadonna; Omar Perbellini; Giovanni Passalacqua; Beatrice Caruso; Sabrina Colarossi; Daniela Dal Fior; Luca Castellani; Chiara Bonetto; Francesco Frattini; Annarita Dama; Giovanni Martinelli; Marco Chilosi; Gianenrico Senna; Giovanni Pizzolo; Roberta Zanotti
Journal:  J Allergy Clin Immunol       Date:  2009-01-09       Impact factor: 10.793

Review 3.  Diffuse cutaneous mastocytosis: Case report and literature review.

Authors:  Anna-Marie Hosking; Joy Makdisi; Francesca Ortenzio; Sebastien de Feraudy; Janellen Smith; Kenneth Linden
Journal:  Pediatr Dermatol       Date:  2018-09-06       Impact factor: 1.588

4.  Evaluation of vaccination safety in children with mastocytosis.

Authors:  Roberta Parente; Valentina Pucino; Diomira Magliacane; Angelica Petraroli; Stefania Loffredo; Giancarlo Marone; Massimo Triggiani
Journal:  Pediatr Allergy Immunol       Date:  2016-10-13       Impact factor: 6.377

5.  Vaccination management in children and adults with mastocytosis.

Authors:  G Zanoni; R Zanotti; D Schena; C Sabbadini; R Opri; P Bonadonna
Journal:  Clin Exp Allergy       Date:  2017-02-27       Impact factor: 5.018

6.  Patterns of anaphylaxis after diagnostic workup: A follow-up study of 226 patients with suspected anaphylaxis.

Authors:  A Ruiz Oropeza; C Bindslev-Jensen; S Broesby-Olsen; T Kristensen; M B Møller; H Vestergaard; H F Kjaer; S Halken; A Lassen; C G Mortz
Journal:  Allergy       Date:  2017-06-20       Impact factor: 13.146

7.  Mastocytosis in children: a protocol for management.

Authors:  Rogier Heide; Auke Beishuizen; Hans De Groot; Jan C Den Hollander; Jasper J Van Doormaal; Jan G R De Monchy; Suzanne G M A Pasmans; Dirk Van Gysel; Arnold P Oranje
Journal:  Pediatr Dermatol       Date:  2008 Jul-Aug       Impact factor: 1.588

8.  Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA).

Authors:  D González de Olano; B de la Hoz Caballer; R Núñez López; L Sánchez Muñoz; M Cuevas Agustín; M C Diéguez; I Alvarez Twose; M C Castells; L Escribano Mora
Journal:  Clin Exp Allergy       Date:  2007-10       Impact factor: 5.018

Review 9.  Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.

Authors:  J M Azaña; A Torrelo; A Matito
Journal:  Actas Dermosifiliogr       Date:  2015-10-30

10.  Cutaneous mastocytosis: Two pediatric cases treated with topical pimecrolimus.

Authors:  Osvaldo Correia; Ana Filipa Duarte; Paula Quirino; Rosa Azevedo; Luis Delgado
Journal:  Dermatol Online J       Date:  2010-05-15
View more
  5 in total

Review 1.  Drugs and Vaccines Hypersensitivity in Children with Mastocytosis.

Authors:  Francesca Mori; Giuseppe Crisafulli; Annamaria Bianchi; Paolo Bottau; Silvia Caimmi; Fabrizio Franceschini; Lucia Liotti; Claudia Paglialunga; Francesca Saretta; Carlo Caffarelli
Journal:  J Clin Med       Date:  2022-06-01       Impact factor: 4.964

Review 2.  COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).

Authors:  Patrizia Bonadonna; Knut Brockow; Marek Niedoszytko; Hanneke Oude Elberink; Cem Akin; Boguslaw Nedoszytko; Joseph H Butterfield; Ivan Alvarez-Twose; Karl Sotlar; Juliana Schwaab; Mohamad Jawhar; Mariana Castells; Wolfgang R Sperr; Olivier Hermine; Jason Gotlib; Roberta Zanotti; Andreas Reiter; Sigurd Broesby-Olsen; Carsten Bindslev-Jensen; Lawrence B Schwartz; Hans-Peter Horny; Deepti Radia; Massimo Triggiani; Vito Sabato; Melody C Carter; Frank Siebenhaar; Alberto Orfao; Clive Grattan; Dean D Metcalfe; Michel Arock; Theo Gulen; Karin Hartmann; Peter Valent
Journal:  J Allergy Clin Immunol Pract       Date:  2021-04-05

Review 3.  Cutaneous mastocytosis in childhood.

Authors:  Katja Nemat; Susanne Abraham
Journal:  Allergol Select       Date:  2022-01-05

Review 4.  Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022.

Authors:  Peter Valent; Karin Hartmann; Patrizia Bonadonna; Marek Niedoszytko; Massimo Triggiani; Michel Arock; Knut Brockow
Journal:  Int Arch Allergy Immunol       Date:  2022-05-23       Impact factor: 3.767

5.  Case Report and Review of the Literature: Bullous Skin Eruption After the Booster-Dose of Influenza Vaccine in a Pediatric Patient With Polymorphic Maculopapular Cutaneous Mastocytosis.

Authors:  Davide Sarcina; Mattia Giovannini; Teresa Oranges; Simona Barni; Fausto Andrea Pedaci; Giulia Liccioli; Clementina Canessa; Lucrezia Sarti; Lorenzo Lodi; Cesare Filippeschi; Chiara Azzari; Silvia Ricci; Francesca Mori
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.